Dose-titration studies of ivermectin against experimental Ancylostoma caninum and Uncinaria stenocephala infections.
Dose-titration trials of ivermectin were conducted on pups with dual experimental infections of 4th-stage larvae or adult Ancylostoma caninum and Uncinaria stenocephala. Ivermectin was administered orally or subcutaneously at dosages of 0.006, 0.012, or 0.024 mg/kg of body weight. Maximal or near maximal (greater than or equal to 96% to 100%) anthelmintic effect was observed for both stages of development for each hookworm species by either route of administration at a dosage of 0.024 mg/kg. Responses for all of the aforementioned categories were linearly related to increasing log dosage of ivermectin, with common slopes (regression coefficients). Regression analysis also provided estimates of the minimal dosages required to produce maximal reduction in worm burden for each stage, species, and route of administration. The estimated ivermectin dosages for maximal efficacy ranged from a low of 0.014 mg/kg for adult A caninum by oral treatment to 0.044 mg/kg for 4th-stage larvae of U stenocephala by oral treatment.
D000284:Administration, Oral; D000722:Ancylostoma / Q000187:drug effects; D000723:Ancylostomatoidea / Q000187:drug effects; D000724:Ancylostomiasis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage* / Q000494:pharmacology; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006725:Hookworm Infections / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D007279:Injections, Subcutaneous / Q000662:veterinary; D007559:Ivermectin; D007783:Lactones / Q000008:administration & dosage* / Q000494:pharmacology; D007814:Larva / Q000187:drug effects; D008297:Male
D000871:Anthelmintics; D007783:Lactones; D007559:Ivermectin